OptiNose, Inc. (OPTN)
Data as of , from SEC Form 4 filings.
See up to 3 months of OPTN. The 7-day demo opens the 1M and 3M ranges and puts OPTN on your watchlist.
Start 7-day demoLatest OPTN insider trades
About OptiNose, Inc. (OPTN)
OptiNose, Inc. files with the SEC under CIK 0001494650 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
OPTN Form 4 activity by transaction type, last 90 days
No Form 4 activity for OPTN in the last 90 days.
OPTN insider transactions (Form 4)
236 Form 4 filings on record, the earliest from Oct 7, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 5,000 | - | - | |
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 3,566 | - | - | |
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 2,133 | - | - | |
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Wilhelmus Cm Groenhuysen - Director | Derivative | Stock Option (Right to Buy) | 1,925 | - | - | |
 R. John Fletcher - Director | Derivative | Stock Option (Right to Buy) | 5,666 | - | - | |
| R. John Fletcher - Director | Derivative | Stock Option (Right to Buy) | 3,566 | - | - | |
| R. John Fletcher - Director | Derivative | Stock Option (Right to Buy) | 4,266 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 5,000 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 3,566 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 2,133 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 1,925 | - | - | |
| Sandra L. Helton - Director | Derivative | Stock Option (Right to Buy) | 962 | - | - | |
| Michael F. Marino III - Officer | Open-market sale | Common Stock | 3,050 | $6.60 | $1K | |
| Ramy A. Mahmoud - Officer | Open-market sale | Common Stock | 4,614 | $6.60 | $2K | |
| Terry Kohler - Officer | Grant or award | Common Stock | 150,000 | $0.00 | - | |
| Terry Kohler - Officer | Grant or award | Stock Option (Right to Buy) | 675,000 | $0.00 | - |
OPTN insider trading FAQ
What is the latest insider trade for OPTN?
OptiNose, Inc. (OPTN) has filed no insider reports in the last 90 days. The most recent on record is dated 21 May 2025. The full record for OPTN runs to 6 Form 4 filings, the earliest from 7 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OPTN stock?
No insider purchases of OPTN were filed in the last 90 days.
How many insiders are selling OPTN stock?
No insider sales of OPTN were filed in the last 90 days. 2 sales are on record for this company.
Where can I see OPTN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OPTN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
6The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Wilhelmus Cm Groenhuysen view on EDGAR
- - R. John Fletcher view on EDGAR
- - Sandra L. Helton view on EDGAR
- - Michael F. Marino III view on EDGAR
- - Ramy A. Mahmoud view on EDGAR
- - Terry Kohler view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where OPTN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OPTN with a 7-day demo
- OPTN on your watchlist
- Every OPTN Form 4 filing on record
- Up to 3 months of OPTN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
